| Literature DB >> 26483059 |
Louis Burt Nabors1, Jana Portnow1, Mario Ammirati1, Joachim Baehring1, Henry Brem1, Paul Brown1, Nicholas Butowski1, Marc C Chamberlain1, Robert A Fenstermaker1, Allan Friedman1, Mark R Gilbert1, Jona Hattangadi-Gluth1, Matthias Holdhoff1, Larry Junck1, Thomas Kaley1, Ronald Lawson1, Jay S Loeffler1, Mary P Lovely1, Paul L Moots1, Maciej M Mrugala1, Herbert B Newton1, Ian Parney1, Jeffrey J Raizer1, Lawrence Recht1, Nicole Shonka1, Dennis C Shrieve1, Allen K Sills1, Lode J Swinnen1, David Tran1, Nam Tran1, Frank D Vrionis1, Stephanie Weiss1, Patrick Yung Wen1, Nicole McMillian1, Anita M Engh1.
Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Central Nervous System (CNS) Cancers provide interdisciplinary recommendations for managing adult CNS cancers. Primary and metastatic brain tumors are a heterogeneous group of neoplasms with varied outcomes and management strategies. These NCCN Guidelines Insights summarize the NCCN CNS Cancers Panel's discussion and highlight notable changes in the 2015 update. This article outlines the data and provides insight into panel decisions regarding adjuvant radiation and chemotherapy treatment options for high-risk newly diagnosed low-grade gliomas and glioblastomas. Additionally, it describes the panel's assessment of new data and the ongoing debate regarding the use of alternating electric field therapy for high-grade gliomas.Entities:
Mesh：
Year: 2015 PMID： 26483059 DOI： 10.6004/jnccn.2015.0148
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908